|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR |
1 Department of Cell Physiology, National Institute for Physiological Sciences, and Graduate University of Advanced Studies (SOKENDAI), Myodaiji, Okazaki 444-8787, Japan
2 Center for Disease Biology and Integrative Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
3 PRESTO, Japan Science and Technology Agency, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan
The role of protein kinase A (PKA) in insulin exocytosis was investigated with the use of two-photon excitation imaging of mouse islets of Langerhans. Inhibitors of PKA selectively reduced the number of exocytic events during the initial period (< 250 s) of the first phase of glucose-induced exocytosis (GIE), without affecting the second phase, in intact islets or small clusters of islet cells. The PKA inhibitors did not reduce the extent of the glucose-induced increase in [Ca2+]i. The actions of glucose and PKA in Ca2+-induced insulin exocytosis (CIE) triggered by photolysis of a caged-Ca2+ compound, which resulted in large increases in [Ca2+]i and thereby bypassed the ATP-sensitive K+ channel-dependent mechanism of glucose sensing, were therefore studied. A high concentration (20 mM) of glucose potentiated CIE within 1 min, and this effect was blocked by inhibitors of PKA. This PKA-dependent action of glucose required glucose metabolism, given that increasing the intracellular concentration of cAMP by treatment with forskolin potentiated CIE only at the high glucose concentration. Finally, PKA appeared to reduce the frequency of kiss-and-run exocytic events and to promote full-fusion events during GIE. These data indicate that a PKA-dependent mechanism of glucose sensing, which is operative even at the basal level of PKA activity, plays an important role specifically in the first phase of GIE, and they suggest that the action of PKA is mediated at the level of the fusion reaction.
(Received 4 October 2005;
accepted after revision 9 November 2005;
first published online 10 November 2005)
Corresponding author N. Takahashi: Division of Basic Medical Sciences (2), Center for Disease, Biology and Integrative Medicine, Graduate School of Medicine, the University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo 113-0033, Japan. Email: norikomd{at}m.u-tokyo.ac.jp
This article has been cited by other articles:
![]() |
G. Kang, C. A. Leech, O. G. Chepurny, W. A. Coetzee, and G. G. Holz Role of the cAMP sensor Epac as a determinant of KATP channel ATP sensitivity in human pancreatic {beta}-cells and rat INS-1 cells J. Physiol., March 1, 2008; 586(5): 1307 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dov, E. Abramovitch, N. Warwar, and R. Nesher Diminished Phosphodiesterase-8B Potentiates Biphasic Insulin Response to Glucose Endocrinology, February 1, 2008; 149(2): 741 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hatakeyama, N. Takahashi, T. Kishimoto, T. Nemoto, and H. Kasai Two cAMP-dependent pathways differentially regulate exocytosis of large dense-core and small vesicles in mouse beta-cells J. Physiol., August 1, 2007; 582(3): 1087 - 1098. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |